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Differential effects of steroids on leukocyte-mediated glomerulonephri-
tis in the rabbit. The effects of steroids on the development of injury in
two models of experimental glomerulonephritis (GN), (one mediated
by neutrophils, the other by macrophages) were compared. The neu-
trophil-associated lesion [initiated by heterologous antiglomerular
basement membrane (GBM) antibody] was characterized by the devel-
opment of an exudative endocapillary GN with heavy neutrophil ac-
cumulation [mean, 6.9 neutrophils/glomerular cross section (N/GCS)
2.9 SD], minor macrophage infiltration [7.9 macrophages/glomerulus
(M/G) 2.2 SD] and heavy proteinuria (1905 mg/24 hr 520 SD). Ster-
oid-treated (methylprednisolone, 2 mg/kg/12 hr iv.) rabbits developed
a marked monocytopenia, mild neutrophilia, and significant reduction
in glomerular macrophage accumulation (0.3 M/G 0.02 SD). However,
neutrophil accumulation (6.1 N/CGS 2.5 SD), histological appear-
ances, and proteinuria (1820 mg/hr 490 SD) were unaffected. The
macrophage-associated model of GN was induced by passive autolo-
gous rabbit anti-sheep IgG 15 hr after the injection of a subnephrito-
genic dose of the same anti-GBM antibody. The glomerular lesion was
characterized by a diffuse endocapillary proliferative GN with heavy
macrophage infiltration (54 M/G 8 SD), insignificant neutrophil ac-
cumulation (0.8 N/GCS 0.02 sn), and the regular development of pro-
teinuria (420 mg/24 hr 80 SD). Steroid-treated rabbits developed a
mild neutrophilia and a significant monocytopenia associated with ab-
rogation of glomerular macrophage accumulation (2.3 M/G 0.8 SD).
This was associated with the prevention of the development of GN and
proteinuria (22 9.5 SD). Thus, steroids produce monocytopenia and
prevent glomerular macrophage accumulation and associated injury
whereas neutrophil accumulation and injury is unaffected. These data
suggest steroids may have widely varying effects on the outcome of
leukocyte-associated experimental GN depending on the nature of the
infiltrating cells.
Effets différentiels des stéroldes sur Ia glomérulonéphrite a mediation
leucocytaire chez le lapin. Les effets des stéroIdes sur le développement
des lesions ont dtd compares dans deux modèles de glomerulonéphrites
expérimentales (GN) (l'une mediee par les neutrophiles, l'autre par les
macrophages). La lesion associëe aux neutrophiles [initialisée par un
anticorps hdterologue anti-membrane basale glomérulaire (GBM)] dtait
caractérisée par le développement d'une GN endocapillaire exsudative
avec une accumulation massive de neutrophiles [en moyenne, 6,9
neutrophiles/section transversale de glomerules (N/GCS) 2,9 SD],
une infiltration macrophagique minime [7,9 macrophages/glomérule
(M/G) 2,2 SD] et une protéinurie massive (1905 mg/24 hr 520 SD).
Des lapins traités avec un stérolde (methylprednisolone 2 mglkgll2 hr
i.v.) ont developpé une monocytopénie marquee, une neutrophilie
modérée, et une reduction significative de l'accumulation macrophag-
ique glomerulaire (0,3 M/G 0,02 SD). Néanmoins l'accumulation
neutrophilique (6,1 N/GCS 2,5 SD), l'aspect histologique, et le
protéinurie (1820 mg/hr 490 SD) n'étaient pas affectés. Le modéle de
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GN associée aux macrophages Ctait produit par injection passive d'IgG
de lapin anti-mouton autologue, 15 heures apres l'injection d'une dose
sub-ndphritogene du méme anticorps anti-GBM. Les lesions
glomerulaires se caractérisaient par une GN proliferative endocapil-
laire diffuse avec infiltration macrophagique massive (54 Mb 8 SD),
une accumulation neutrophilique insignifiante (0,8 N/GCS 0,02 SD),
et l'apparition rdguliere d'une protéinurie (420 mg124 hr 80 SD). Des
lapins traités avec le stéroIde ont ddveloppd une neutrophilie modérée
et une monocytopenie significative associées a Ia suppression de
l'accumulation macrophagique glomérulaire (2,3 M/G 0,8 SD). Cela
allait de pair avec Ia prevention du developpement de Ia GN et de la
f,rotéinurie (22 9,5 SD). Ainsi, les stdroIdes produisent une
monocytopenie et préviennent l'accumulation glomerulaire de macro-
phages et les lesions associées tandis que l'accumulation neutrophil-
ique et ses lesions ne sont pas affectées, Ces donnCes suggCrent que
les stéroldes pourraient posséder des effets largement variables sur le
devenir des GN expérimentales associées aux leucocytes selon Ia na-
ture des cellules infiltrantes,
The effect of steroids on the course of human glomerulo-
nephritis is controversial [1—6], and there is no current rational
basis for selecting particular types of glomerulonephritis in
which they may have potential benefit. However, much is
known of their effects on many components of the inflamma-
tory systems thought to be important as mediators of injury in
glomerulonephritis. In particular, their effect on circulating leu-
kocytes has been well demonstrated [7—221. Cells of the
macrophage/monocyte system show a particular vulnerability
to glucocorticoid administration in therapeutic dose levels. A
profound monocytopenia is associated with steroid administra-
tion and most of the specialized functions of these cells are de-
pressed. Neutrophil function, however, is relatively refractory
to the use of steroids and a neutrophil leukocytosis follows
their administration. Thus, it would appear that steroids are of
greater potential benefit in macrophage-associated forms of
glomerulonephritis. Macrophages have been shown recently to
be prominent participants in immunologically induced glomer-
ular damage, both in human disease [23—29] and experimental
glomerulonephritis [30—37] Evidence has also been accumulat-
ing that they are important mediators of glomerular injury
[3 1—32]. Neutrophils have also been shown to be capable of in-
ducing glomerulonephritis [38] although in different experimen-
tal models. It was therefore decided to compare the effects of
steroids in neutrophil and macrophage-dependent models of
glomerular injury to assess the place for steroid treatment in
proliferative glomerulonephritis associated with a significant
circulating leukocyte infiltration.
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Methods
Animals. New Zealand white rabbits, weighing 1.6 to 2.5 kg,
were used.
Experimental models of injury
Heterologous anti-GBM antibody-induced glomerulonephri-
tis. This was initiated by the single intravenous injection of
sheep anti-rabbit GBM antibody (35 g/g kidney fixing anti-
body, KFA). Rabbits were kept in metabolic cages for 24 hr
and urine was collected for the assessment of proteinuria. Af-
ter 24 hr the rabbits were sacrificed and the kidneys were re-
moved for subsequent examination.
Passive autologous anti-GBM antibody-induced glomerulo-
nephritis. This model was initiated with a subnephritogenic
intravenous dose of the same sheep anti-rabbit anti-GBM anti-
body used above (6.2 g/g KFA) followed 15 hr later by pas-
sive rabbit anti-sheep gamma globulin serum (4.5 g/g KFA).
Urine was collected over the 24-hour period following the ad-
ministration of the passive autologous antibody for the assess-
ment of proteinuria. Animals were sacrificed at this time, and
the kidneys were removed and assessed as outlined below.
Histological assessment
Portions of kidney cortex were fixed in Bouin's fixative, em-
bedded in paraffin, sectioned at 2 sm, and stained with H & E
and periodic acid Schiff's reagent.
Assessment of proteinuria
Proteinuria was assessed by a turbidometric method using a
final concentration of 2.5% sulphosalicylic acid [391. Light
transmission was recorded spectrophotometrically (Farrant
Optical Co., New York, New York) at 610 nm and the protein
concentration determined from comparison with a standard
curve made up from bovine serum albumin (BSA).
Leukocyte counts
Monocyte identification was determined by the use of two
monocyte specific histochemical stains for the presence of non-
specific esterase: the alpha naphthol acetate method [40] and
the alpha naphthol butyrate method [41]. Differential counts
were performed on 200 cells stained with each method and the
final differential count was expressed as the mean of counts ob-
tained by both methods.
Assessment of glomerular macrophages
The presence of macrophages within glomeruli was assessed
by the technique of glomerular cell culture. At the time of sac-
rifice, portions of renal cortex were removed in a sterile man-
ner, and glomeruli were isolated as previously described
[32—34, 42]. The isolated glomeruli were grown in individual
drops of tissue culture medium (Modified Eagle's Minimal Es-
sential Medium with 10% fetal calf serum, Commonwealth Se-
rum Laboratories, Melbourne, Australia). After 3 days in cul-
ture the number of macrophages emerging from the isolated
glomeruli was assessed. At least 10 glomeruli/kidney were as-
sessed and the results were expressed as the mean number of
macrophages/glomerulus.
Assessment of glomerular neutrophils
Neutrophils were observed in glomeruli stained with peri-
odic acid Schiff's reagent and cut in equatorial sections. At least
15 glomeruli were assessed per kidney. The results were expressed
as the mean number of neutrophils/glomerular cross-section.
Leukocyte depression with nitrogen mustard
Depression of circulating leukocytes was induced by the
intravenous injection of nitrogen mustard. An initial dose of 1.7
mg/kg was given followed 36 hr later by 1 mg/kg [32].
Steroid treatment
Methylprednisolone, 2 mg/kg iv., was administered 30 mm
prior to the injection of the disease-inducing antibodies. This
dose was repeated at 12-hr intervals until sacrifice.
Experimental design
With both experimental models, three groups, each of 12
rabbits were defined: untreated controls, nitrogen mustard, and
steroid-treated rabbits. Circulating leukocyte counts were ob-
tained prior to the commencement of each experiment then at
regular intervals subsequently. After the rabbits were injected
with disease-initiating antibodies, they were placed in meta-
bolic cages and a 24-hr urine collection was obtained to assess
proteinuria. At this time the animals were sacrificed. The kid-
neys were then removed to assess histological appearances and
the number of neutrophils and macrophages that had accumu-
lated per glomerulus.
Two further groups of rabbits (each comprised of eight ani-
mals) were included to assess the influence of steroids on pas-
sive autologous disease induced by increased amounts of pas-
sive autologous antibody. In one group a dose of antibody was
administered to give a mean kidney binding of 9.0 g/g and 13.5
sgIg in the second group.
Results
Heterologous phase anti-GBM antibody-induced
glomerulonephritis
Untreated rabbits
Leukocyte levels. The injection of heterologous anti-GBM
antibody was associated with a minor transient elevation in the
levels of neutrophils, lymphocytes, and monocytes. However,
the numbers of these cells all returned to the pre-injection
range within 4 hr and did not alter during the development of
glomerulonephritis (Fig. 1).
Histological appearances. Animals injected with heterolo•
gous anti-GBM antibody developed a diffuse exudative prolif-
erative glomerulonephritis (Fig. 2). The most prominent fea-
ture of the lesion was the accumulation of neutrophils. Endo-
thelial cell swelling and injury could also be observed at the
light microscopic levels.
Glomeru/ar neutrophil accumulation. A mean of 6.9 2.9 SD
neutrophils could be observed per glomerular cross section (Fig. 3).
Glomerular macrophage accumulation. A mean 7.8 2.2 SD
macrophages were observed per glomerulus at the time of sac-
rifice (Fig. 3).
Proteinuria. All animals developed heavy proteinuria (mean,
1905 g/24 hr 520 SD, Fig. 3).
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Fig. 2. Photomicrograph qf a glomerulus from a rabbit with anti-GBM
antibody-induced glomerulonephritis. An endocapillary glomerulone-
phritis with predominant neutrophil accumulation developed is shown.
(Original x 120)
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Fig. 1. The level of circulating neutrophils, lymphocytes and mono-
cytes in (untreated, 0—0; nitrogen mustard, X—X; and steroid-treated,
•—•) rabbits developing anti-GBM antibody-induced glomerulone-
phritis. All numbers are expressed as mean SD.
Nitrogen mustard-treated rabbits
Leukocyte levels. Animals pretreated with nitrogen mustard
developed a severe pan-leukopenia (Fig. 1). Levels of neutro-
phils and monocytes were both reduced to 10% of pretreat-
ment levels. Lymphocytes were also significantly reduced but
to a lesser extent.
histological appearances. Animals pretreated with nitrogen
mustard did not develop significant glomerular lesions (Fig. 4).
Glomerular neutrophil accumulation. Nitrogen mustard was
associated with almost complete abrogation of neutrophil ac-
cumulation (mean, 0.4 neutrophils/glomerular cross-section
0.08 5D P < 0.05; Fig. 3).
Glomerular macrophage accumulation. Nitrogen mustard
pretreatment prevented the minor macrophage accumulation
that was observed in untreated animals (mean, 0.6
macrophages/glomerulus 0.07 SD; P < 0.05; Fig. 3).
Proteinuria. Animals treated with nitrogen mustard did not
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Fig. 3. The extent of proteinuria and numbers of neutrophils and mac-
rophages accumulating in glomeruli of rabbits developing anti-GBM anti-
body-induced glomerulonephritis. All numbers are expressed as mean SD.
develop significant proteinuria (mean, 14 mg124 hr 6 s; Fig.
3). This was not significantly different from levels seen with
normal animals.
S
aFig. 5. Photomicrograph of a glomerulus from a rabbit injected with
anti-GBM antibodies and treated with methyiprednisolone. A marked
endocapillary glomerulonephritis developed with prominent neutrophil
accumulation. (Original x 120)
Steroid-treated rabbits
Leukocvte levels. The injection of methyiprednisolone in-
duced neutrophilia and reduced the levels of both lymphocytes
and monocytes. Lymphocytes were least affected while mono-
cyte levels were reduced to less than 10% of pretreatment lev-
els (Fig. 1).
Histological appearances. Steroids had no effect on the
histological appearances of the glomeruli of animals injected
with heterologous anti-GBM antibodies (Fig. 5). A marked exu-
dative endocapillary proliferative glomerulonephritis exactly
similar to that of untreated animals was observed.
Glomerular neutrophil levels. Steroids made no difference to
the glomerular accumulation of neutrophils (mean, 6.1
neutrophils/glomerular cross-section 2.5 SD, Fig. 3).
Glomerular macrophage accumulation. The minor macro-
phage accumulation observed in untreated animals was abro-
E
E,.-
.E0
2x
a)z
Time, hours
Fig. 6. The level of circulating neutrophils, lymphocytes, and mono-
cytes in untreated (0—0), nitrogen mustard (X—X), and steroid-treated
(•—•)animals developing a passive model of the autologous phase of
anti-GBM antibody-induced glomerulonephritis. All figures are ex-
pressed as mean SD.
gated by the use of steroids (mean, 0.3 macrophages!
glomerulus 0.02 SD). This was significantly less than the
numbers observed in untreated animals (P < 0.01) and not sig-
nificantly different from the levels found following nitrogen
mustard treatment (Fig. 3).
Proteinuria. Development of proteinuria was not affected by
the use of steroids (mean, 1820 mg124 hr 490 SD).
Passive autologous model of anti-GBM antibody-induced
glomerulonephritis
Untreated rabbits
Leukocyte levels. Animals developing the passive autolo-
gous model of glomerulonephritis were observed to have a mild
transient biphasic neutrophilia associated with the injection of
each antibody (Fig. 6). However, the levels of neutrophils soon
returned to the pretreatment range. There was a slight but in-
significant elevation in lymphocyte counts in this model, but
the most significant effect was a marked monocytosis ob-
served throughout the duration of the model (Fig. 6).
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Fig. 4. Photomicrograph of a glomerulus from a rabbit treated with ni-
trogen mustard prior to the injection of anti-GBM antibody. No sig- ii
nificant lesion was developed. (Original x 120). 32x
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Histological appearances. Rabbits injected with passive
autologous antibody developed an endocapillary proliferative
glomerulonephritis. This was a diffuse lesion affecting all
glomeruli with the predominant features being a marked in-
crease in the numbers of intracapillary mononuclear cells (Fig.
7),
Glomerular neutrophil accumulation. A mean of only 0.8
neutrophils/glomerular cross-section 0.2 SD was observed
(Fig. 8). This was not significantly different from the numbers
of neutrophils seen in the glomeruli of normal animals (0.4
neutrophils/glomerular cross-section 0.1 SD).
Glomerular macrophage accumulation. A marked macro-
phage accumulation was observed in this model (mean, 54
macrophages/glomerulus 8 SD, Fig. 8).
Proteinuria. Significant proteinuria was observed in all ani-
mals (mean, 420 mg/24 hr 80 SD, Fig. 8).
Nitrogen mustard-treated rabbits
Leukocyte levels. As seen with the heterologous model, pre-
treatment with nitrogen mustard produced a severe panleu-
kopenia. Again neutrophils was the cell population most af-
fected with a 90% reduction from pretreatment levels while
lymphocyte levels were the least affected. A profound mono-
cytopenia was sustained throughout the duration of the experi-
ment (Fig. 6).
Histological appearances. Pretreatment with nitrogen mus-
tard prevented the development of glomerulonephritis (Fig. 9).
Glomerular neutrophil accumulation. Following the use of
nitrogen mustard a mean of 0.2 neutrophil/glomerular cross-
section 0.04 SD was observed (Fig. 8). This was not signifi-
cantly different from the number of neutrophils observed
in the glomeruli of untreated animals developing this type of
glomerulonephritis.
Macrophage accumulation. Nitrogen mustard prevented
glomerular macrophage accumulation (mean, 0.6 macro-
phages/glomerulus 0.2 SD; P < 0.05; Fig. 8).
Proteinuria. Nitrogen mustard4reated animals did not de-
velop significant proteinuria (mean, 12 mg/24 hr 4 SD, Fig.
7).
Antibody-bound,
tig/g 4.5 4.5 9.0 13.5
Proteinuria,
mg/24hr 420 80 22 7.5 38.2 21.2 46.3 18.6
Macrophages/
glomerulus 54 8 2.3 0.8 6.8 2.9 7.2 4.1
Steroid-treated rabbits
Leukocyte levels. Results similar to those seen in steroid-
treated rabbits developing heterologous anti-GBM antibody-in-
duced GN were observed. There was a neutrophilia in re-
sponse to steroid injection while the monocyte levels were pro-
foundly reduced. Lymphocyte levels were only partially re-
duced (Fig. 6).
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Fig. 7. A photomicrograph of a glomerulus from a rabbit with passive
autologous anti-GB M-induced glomerulonephritis. A severe endocapil-
lary glomerulonephritis was observed in all animals. (Original x 120)
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Fig. 8. The extent of proteinuria and numbers of neutrophils and mac-
rophages accumulating in the glomeruli of rabbits with a passive
model of the autologous phase of anti-GBM antibody-induced
glomerulonephritis. All figures are mean SD.
Table 1. Effect of steroids in preventing the macrophage accumulation
and proteinuria induced by the deposition of increasing quantities of
passive autologous rabbit anti-sheep globulin serum
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in the extent of proteinuria and macrophage infiltration was ob-
served with higher levels of kidney-bound antibody, but these
were all significantly less than that observed in untreated rab-
bits given the lowest level (4.5 ig/g) of passive autologous anti-
body (all values P < 0.05).
Discussion
Fig. 9. A photomicrograph of a glomerulus from a rabbit treated with
nitrogen mustard prior to the induction of passive autologous anti-
GBM-induced glomerulonephritis. No significant glomerular lesion de-
veloped. (Original x 120)
Fig. 10. A photomicrograph of a glomerulus from a rabbit treated with
met hyiprednisolone during the development of passive autologous
anti-GBM-induced glomerulonephritis. The development of glomeru-
lonephritis was prevented. (Original x 120)
Histological appearances. Steroid-treated animals did not
develop a significant glomerular lesion (Fig. 10).
Glomerular neutrophil accumulation. Steroid-treated ani-
mals had a mean of 0.6 neutrophils/glomerular cross-section
0.2 SD (Fig. 8).
Glomerular macrophage accumulation. Steroid usage was
associated with a significant reduction in the levels of glomer-
ular macrophages (mean, 2.3 macrophages/glomerulus 0.8
SD; P < 0.05; Fig. 8).
Proteinuria. Steroid-treated animals did not develop signifi-
cant proteinuria (mean, 22 mg/24 hr 7,5 SD; P < 0.01; Fig.
7).
The effect of steroids on injury induced by increasing
quantities of passive autologous antibody
Steroid treatment still afforded substantial protection from
injury when increasing quantities of disease induced passive
autologous antibody were administered (Table 1). An increase
Recent studies have shown that neutrophils and macro-
phages are important mediators of injury in experimental gb-
merulonephritis [31, 32, 38]. As steroids are known to pro-
foundly influence macrophage function, it was felt likely that
these agents may abrogate macrophage-mediated glomerular
injury. The current experiments strongly support this hypoth-
esis. Neutrophil function is more resistant to steroid action,
and neutrophil-induced glomerular injury was found to be un-
affected by steroid therapy.
The two experimental models of glomerulonephritis studied
proved suitable to compare the effects of steroids on neu-
trophil- and macrophage-mediated injury. Injury did not occur
in either model in rabbits with nitrogen mustard-induced pan-
leukopenia, confirming that injury depended on circulating leu-
kocytes. In the heterologous anti-GBM antibody-induced
model the predominant infiltrating leukocyte was the neu-
trophil with only a minor macrophage accumulation.
Unlike neutrophils (easily recognized by routine light mi-
croscopy), macrophages do not have unique cytological fea-
tures to allow their participation in glomerular injury to be as-
sessed by routine histology. Therefore, the technique of
glomerular cell culture, previously shown to be capable of af-
fording a semiquantitative evaluation of macrophage accumu-
lation, was employed [32, 34, 361. As neutrophils do not read-
ily survive in tissue culture, they cannot be evaluated by this
technique so two different methods of assessing leukocyte ac-
cumulation were necessary.
The two models were chosen for study because there was
clearly a major difference in the nature of the infiltrating cells.
In fact, the models were deliberately contrived to produce
these results so that the effect of steroids on injury induced by
these two cell populations could be compared.
Heterologous anti-GBM antibody is known to produce in-
jury by complement activation and consequent neutrophil at-
traction [38]. It is also known that a threshold (the nephrito-
genic threshold) quantity of antibody must be bound before in-
jury occurs [38]. In the macrophage-related model of injury a
subnephritogenic dose of antibody was used so that neutrophil
accumulation would be minimal. Macrophage accumulation is
far greater in the autologous phase of injury than the hetero-
bogous phase [33]. This fact was exploited to augment
macrophage accumulation in the passive model by injecting
passive autobogous rabbit antibody. A previous study has con-
firmed that this same lesion is due to macrophages [32]. A more
recent dissection of this model has shown that immune adher-
ence to the Fc portion of the autologous disease inducing IgG
is the major mechanism of macrophage accumulation [43].
Complement has been shown to play no role in this lesion [32].
The difference in effect of heterologous anti-GBM antibody and
passive autologous antibody in attracting different inflamma-
tory cells is thus likely to be due to the greater potential for the
autobogous antibody to facilitate autologous immune adher-
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ence of macrophages while the heterologous antibody initiates
complement-mediated neutrophil ingress.
Steroids are known to affect both antibody production and
cell-mediated immunity, but, in the short-term, passive models
studied no potential for either of these mechanisms exists.
Thus, in these experiments the effect of methylprednisolone on
macrophage and neutrophil mediation of glomerular injury
could be directly compared.
It is possible that the protection from injury afforded by ster-
oids in the passive autologous model is related to the quantity
of antibody binding to the kidney. However, despite substan-
tial increases in the levels of injected passive antibody signifi-
cant protection from both proteinuria and macrophage ingress
was observed. A trend toward greater macrophage infiltration
and proteinuria was observed suggesting that either the
macrophage mediation system may become less responsive to
steroids under these conditions or that other steroid-indepen-
dent mediators may be brought into play.
A limitation of both models is the short duration of injury.
This was deliberately contrived so active immune responses
would be avoided, but it meant that studies of the effects of
steroids on established disease could not be usefully carried
out as many animals lost their proteinuria spontaneously after
the initial 24-hr collection period.
Steroids were found to have a significant effect on the levels
of circulating leukocytes. The well known neutrophilia that is
associated with their use was confirmed in both experimental
models. The predominant suppressive effect of steroids was on
the levels of circulating monocytes with a minor reduction in
lymphocytes. Similarly, steroid administration prevented the
accumulation of neutrophils. These data provide strong evi-
dence for studying the origin of the infiltrating leukocytes in
glomerulonephritis. The observations suggest that experimen-
tal macrophage-associated glomerular injury is susceptible to
steroid administration while neutrophil injury is refractory.
These results do not negate other possible actions of steroids
in glomerulonephritis, particularly on antibody production and
potential lymphocyte-directed delayed hypersensitivity
involvement.
The controversial reports of the effectiveness of steroids on
human proliferative glomerulonephritis may relate to the rela-
tive participation and steroid sensitivity of each of the indi-
vidual inflammatory mediator systems in differing forms of hu-
man glomerulonephritis. Steroids are known to affect human
leukocytes in a manner similar to that seen in the current stud-
ies. Systemic administration induces a monocytopenia with an
associated neutrophilia [8—12]. it is also known that human
neutrophil function is relatively unaffected by steroids while
cells of the monocyte/macrophage series appear particularly
vulnerable to this drug [7—22]. Steroids inhibit the response of
monocytes to several chemotactic factors in vitro [15, 19] and
depress their normal bactericidal and fungicidal activity in cul-
ture [13, 14, 201. They antagonize the effect of macrophage mi-
gration inhibition factor on monocytes [15, 19] and repress re-
ticuloendothelial clearance of both opsonized and non-opsin-
ized materials [16] and lead to decreased accumulation of
monocytes in inflammatory sites [7, 18]. Other important ef-
fects include the in vitro inhibition of monocyte IgU and com-
plement receptors in a dose-response fashion [21] and a marked
decrease in the secretion of collagenase, elastase, plasminogen
activator, and neutral proteases [22].
The current data suggest that in the future the study of hu-
man renal biopsies should be expanded to include a profile of
the infiltrating leukocytes and that specific pharmacological
agents may have relative indications depending on which in-
flammatory pathways are involved. Macrophage-induced pro-
liferative glomerulonephritis may be potentially susceptible to
intervention with steroids.
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